CN Patent

CN106414433A — 作为脾酪氨酸激酶抑制剂的二氮杂螺烷酮取代的噁唑衍生物

Assigned to AB Science SA · Expires 2017-02-15 · 9y expired

What this patent protects

本发明涉及二氮杂螺烷酮取代的噁唑衍生物，所述衍生物选择性地调整、调节和/或抑制由某些天然和/或突变的蛋白激酶介导的信号转导，所述蛋白激酶与多种人和动物的疾病(如细胞增殖病症、代谢病症、自身免疫病症、变应性病症和退行性病症)有关。尤其是，本文所公开的化合物为Syk抑制剂。

USPTO Abstract

本发明涉及二氮杂螺烷酮取代的噁唑衍生物，所述衍生物选择性地调整、调节和/或抑制由某些天然和/或突变的蛋白激酶介导的信号转导，所述蛋白激酶与多种人和动物的疾病(如细胞增殖病症、代谢病症、自身免疫病症、变应性病症和退行性病症)有关。尤其是，本文所公开的化合物为Syk抑制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN106414433A
Jurisdiction
CN
Classification
—
Expires
2017-02-15
Drug substance claim
No
Drug product claim
No
Assignee
AB Science SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.